Master Alliance Provisions Guide (MAPGuide)

IMI 2 Joint Undertaking Model Consortium Agreement

  • Intellectual Property | Protection of IP

7. Intellectual Property – General Provisions on Results

7.4 Protection of Results

7.4.1 General Commitment to Protect Results. […] Each Beneficiary agrees to examine the possibility of protecting its Results, and, where appropriate, adequately protect them by any means for an appropriate period and within appropriate territorial coverage if: a) the Results can reasonably be expected to be commercially or industrially exploited, and b) protecting them is possible, reasonable and justified (given the circumstances).

When deciding on the protection of Results, the Beneficiary must consider the legitimate interest of its own and other Beneficiaries. Means of protection may include, but are not limited to, patenting or maintaining the Results as confidential know-how.

7.4.2 Patents – Inventorship, assignment and inventor remuneration.

7.4.2.1 Each Beneficiary shall enter or have entered into appropriate (employment) agreements with its employees, agents and personnel, and have directed its Affiliated Entities, Linked Third Parties and Sub-Contractors, if any, to enter or have entered into agreements with their employees, agents and personnel, providing that each such employee, agent or personnel transfers the full ownership to any Results to such Beneficiary, unless this is already provided for automatically under applicable law.

7.4.3 Mandatory Messaging in connection with Results. Unless the IMI2 JU requests or agrees otherwise or unless it is impossible, applications for protection of Results filed on or behalf of a Beneficiary must include the following: “The project leading to this application has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement n° [number]. This Joint Undertaking receives the support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.”